We Ran A Stock Scan For Earnings Growth And McKesson (NYSE:MCK) Passed With Ease
Is McKesson Stock Underperforming the Dow?
McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions
McKesson Announces Completion Of Previously-Announced $1.25B Minority Ownership Investment By Apollo Funds For 13% Of MCK Subsidiary Medical-Surgical Solutions
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Nanoscope Therapeutics Selects InspiroGene by McKesson to Support Distribution of Novel Retinal Therapy
$1000 Invested In McKesson 5 Years Ago Would Be Worth This Much Today
A Look Back at Healthcare Providers & Services Stocks’ Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
TBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off?
Ontada Integrates Florida Cancer Specialists & Research Institute Data to Enrich Its Data Ecosystem
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Avoid
What Makes McKesson Corporation (MCK) an Attractive Bet?
McKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of Time
McKesson Corporation (MCK) Surged 50% on Strong Earnings Growth and Resilient Drug Distribution Model
1 S&P 500 Stock to Target This Week and 2 We Avoid
5 Insightful Analyst Questions From McKesson’s Q1 Earnings Call
Wells Fargo Maintains Overweight Rating on Cencora (COR)
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?
Citigroup Maintains Buy on McKesson, Lowers Price Target to $945
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.